Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Muffly, Lori; C. Pasquini, Marcelo; J. Martens, Michael; Brazauskas, Ruta; Zhu, Xiaochun; Adekola, Kehinde; Aljurf, Mahmoud; K. Ballen, Karen; Bajel, Ashish; Baron, Frédéric; Battiwalla, Minoo; Beitinjaneh, Amer; Cahn, Jean‐Yves; Carabasi, Mathew; Chen, Yi‐Bin; Chhabra, Saurabh; O. Ciurea, Stefan; A. Copelan, Edward; D’Souza, Anita; Edwards, John; M. Foran, James; O. Freytes, César; C. Fung, Henry; Peter Gale, Robert; Giralt, Sergio; K. Hashmi, Shahrukh; Hildebrandt, Gerhard; T. Ho, Vincent; A. Jakubowski, Ann; M. Lazarus, Hillard; R. Luskin, Marlise; Martino, Rodrigo; T. Maziarz, Richard; L. McCarthy, Philip; Nishihori, Taiga; L. Olin, Rebecca; F. Olsson, Richard; Pawarode, Attaphol; Peres, Edward; R. Rezvani, Andrew; A. Rizzieri, David; N. Savani, Bipin; C. Schouten, Harry; Sabloff, Mitchell; D. Seftel, Matthew; Seo, Sachiko; L. Sorror, Mohamed; Szer, Jeff; Wirk, Baldeep; A. Wood, William; Artz, Andrew

doi:10.1182/blood-2017-03-772368

Public

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Published in Blood • Jul 3, 2017

Authors:

Lori Muffly

Marcelo C. Pasquini

Michael J. Martens

Abstract

Key Points Over the last decade, allogeneic HCT has been increasingly administered in the United States to adults aged 70 and older with hematologic malignancies. Allogeneic transplant outcomes were reasonable; high comorbidity and ablative conditioning regimens were associated with inferior outcome...

Subject

Medicine

Hematopoietic cell

Transplantation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!